On World Malaria Day 2012, WHO hails global progress in combating malaria but highlights the need to further reinforce the fight. The Global Malaria Programme’s new initiative, T3: Test. Treat. Track, urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build stronger malaria surveillance systems.
InIn view of the increasing demand of countries to scale-up malaria diagnostics following the largescale introduction of expensive antimalarial medicines, and the decreasing malaria trends in many countries, there is a need for guidance in the selection of malaria rapid diagnostics that meet international quality standards.
This Training module on malaria control: Entomology and vector control has been developed to improve the knowledge and skills of entomologists and vector control staff as well as of managers/senior health officers involved in malaria vector control at programme level. It is designed to provide guidance on relevant aspects of malaria entomology and vector control including identification and sampling of malaria vectors, incrimination of malaria vectors, selection between different vector control options, and monitoring and management of insecticide resistance.
This Training module on malaria control: Case management has been developed by WHO to improve the knowledge and skills of both health professionals involved in planning malaria case management as part of control and elimination programmes and clinicians managing malaria patients.
This report from the Communicable Disease-Malaria Program, Area of Health Surveillance and Disease Prevention and Control, Pan American Health Organization is an epidemiological analysis of the situation of malaria in the Americas in 2008.
There have been many challenges in the development and consolidation of this Regional Strategic Plan for Malaria which focuses on the 2006–2010 period. It takes into account the need for continuous efforts to achieve specific goals as well as the reduction of the burden on human health and the negative social and economic effects of the disease among the most affected population groups. Nevertheless, there is consensus that strategies must be of optimum relevance to the realities of the malaria situation in the region and among its member territories.
Resistance of Plasmodium falciparum to antimalarial drugs is one of the most serious challenges facing national malaria control programs in the Americas. At present, P. falciparum is resistant to both chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) throughout the Amazon Basin and to CQ alone on the Pacific Coast of South America.
Regional Office for the Americas of the World Health Organization